Morepen Laboratories Ltd Financials
Company Logo

Morepen Laboratories Ltd Financial Statement

Morepen Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue395.38
Operating Expense372.33
Net Profit8.06
Net Profit Margin2.04
Earning Per Share0.15
EBIDTA23.04
Effective Tax Rate14.28

Morepen Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual1,554.54
Operating Expenses Annual1,401.12
Operating Profit Annual169.13
Interest Annual7.10
Depreciation24.44
Net Profit Annual101.58
Tax Annual36.01

Morepen Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning15.30
Cash Flow from Operations29.08
Cash Flow from Investing-280.42
Cash Flow from Financing260.47
Cash Flow at the End24.43

Morepen Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)10.88
PBIT Margin (%)9.31
PBT Margin (%)8.00
Net PROFIT Margin (%)6.53
Return On Networth / Equity (%)9.81
Return On Networth /Employed (%)12.79
Return On Assets (%)8.95
Total Debt / Equity (X)0.06
Asset Turnover Ratio (%)1.37

Morepen Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual365.87
Total Current Assets Annual1,106.78
Non Current Assets Annual614.42
Total Shareholders Funds Annual1,181.50
Total Assets Annual1,721.20

Morepen Laboratories Ltd Earning Calls

EPS (INR)

Expected

0.20

Reported

0.20

Surprise

0.00%

Mar 2025

EPS beaten by 0.00%

Dec 2024

EPS beaten by -5.41%

Sep 2024

EPS beaten by 0.00%

FAQS on Morepen Laboratories Ltd Financials

As of Sep 7, 2025, Morepen Laboratories Ltd has a market capitalization of 2,621.96 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Morepen Laboratories Ltd is with a debt-to-equity ratio of 0.08.

In FY 2024 , Morepen Laboratories Ltd recorded a total revenue of approximately 1,554.54 Cr marking a significant milestone in the company's financial performance.

Morepen Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..

Morepen Laboratories Ltd's current PE ratio is 25.81.

Morepen Laboratories Ltd's ROCE averaged 12.0% from the FY ending March 2023 to 2025, with a median of 11.3%. It peaked at 16.6% in March 2024, reflecting strong capital efficiency over the period..

Morepen Laboratories Ltd's latest EBIT is Rs. 144.69 Cr, surpassing the average EBIT of Rs. 120.73 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions